
Interviews
Fynlee Hateley: the 13-year-old Parkinson’s campaigner
The boy has raised UK £1,000 for the condition
READ MOREMore than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.
The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.
Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.
The boy has raised UK £1,000 for the condition
READ MOREJoe Lacy shares his diary from the World Parkinson Congress 2019
READ MORELearn about the US National Plan to End Parkinson’s Act
READ MORE
Comments